List of insiders holdings for Marker Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Sonsini Peter W. 10% Owner | 2021-03-18 17:17:55 | 0 10,714,285 | 10,714,285 | Form 4 |
| 2 | MAKOWER JOSHUA 10% Owner | 2021-03-18 17:16:26 | 0 10,714,285 | 10,714,285 | Form 4 |
| 3 | BARRIS PETER J 10% Owner | 2018-10-18 16:48:13 | 0 8,750,000 | 8,750,000 | Form 3 |
| 4 | MOTT DAVID M 10% Owner | 2018-10-18 16:51:37 | 0 8,750,000 | 8,750,000 | Form 3 |
| 5 | Viswanathan Ravi 10% Owner | 2018-10-18 16:52:58 | 0 8,750,000 | 8,750,000 | Form 3 |
| 6 | JEFFERIES WILFRED Chief Scientist Officer 10% Owner | 2004-02-17 17:22:35 | 2,000,000 2,770,465 | 4,770,465 | Form 5 |
| 7 | Eastern Capital LTD Portfolio Services Ltd. DART KENNETH BRYAN 10% Owner | 2021-03-15 16:45:13 | 3,966,668 0 | 3,966,668 | Form 13D |
| 8 | Jefferies Wilfred Arthur 10% Owner | 2007-07-19 20:35:23 | 3,551,902 0 | 3,551,902 | Form 13D |
| 9 | CORIN DENIS President | 2012-04-20 17:55:29 | 2,561,202 0 | 2,561,202 | Form 4 |
| 10 | Leen Ann M. Chief Scientific Officer | 2021-03-23 19:45:14 | 2,415,842 0 | 2,415,842 | Form 13D |
| 11 | New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC BASKETT FOREST Chang Carmen Behbahani Ali Florence Anthony A. Jr. Makhzoumi Mohamad SANDELL SCOTT D Walker Paul Edward 10% Owner | 2024-12-23 16:40:48 | 1,625,678 0 | 1,625,678 | Form 4 |
| 12 | HANDFORD RONALD L President/CEO 10% Owner | 2004-02-17 17:21:56 | 558,000 908,000 | 1,466,000 | Form 5 |
| 13 | MOORE TRACY A Chief Financial Officer | 2009-10-16 18:19:03 | 500,000 0 | 500,000 | Form 4 |
| 14 | Hoang Peter L. President and CEO | 2022-03-28 21:06:03 | 483,286 0 | 483,286 | Form 4 |
| 15 | MCGOWAN PATRICK A Secretary, Treasurer & CFO | 2007-07-03 18:42:37 | 381,432 0 | 381,432 | Form 3 |
| 16 | DePippo Lynn Director | 2011-09-28 10:38:00 | 358,696 0 | 358,696 | Form 3 |
| 17 | GENEMAX CORP Director | 2004-02-17 17:48:38 | 275,000 0 | 275,000 | Form 5 |
| 18 | ATKINS GRANT Chief Financial Officer | 2004-02-17 17:21:04 | 250,000 0 | 250,000 | Form 5 |
| 19 | ATKINS GRANT R Chief Financial Officer | 2004-02-17 17:17:03 | 250,000 0 | 250,000 | Form 4 |
| 20 | WILSON GLYNN Director | 2018-10-10 16:50:47 | 181,776 0 | 181,776 | Form 4 |
| 21 | Silverman Joshua Director | 2018-10-17 08:54:51 | 17,221 153,333 | 170,554 | Form 4 |
| 22 | LINDSAY ALAN P Director | 2009-03-20 19:42:46 | 0 162,000 | 162,000 | Form 4 |
| 23 | Kim Anthony H. Chief Financial Officer | 2022-03-28 21:03:28 | 114,436 0 | 114,436 | Form 4 |
| 24 | Konstantine Sarafis Chief Operating Officer | 2004-09-15 14:17:03 | 100,000 0 | 100,000 | Form 3 |
| 25 | Farrauto Edward Chief Financial Officer | 2004-05-27 10:56:11 | 0 100,000 | 100,000 | Form 3 |
| 26 | PEARSON TERRY W DR Director | 2004-02-17 17:30:52 | 100,000 0 | 100,000 | Form 3 |
| 27 | Laskow-Pooley David Director | 2022-05-26 16:10:53 | 80,000 0 | 80,000 | Form 4 |
| 28 | Wasserman Frederick Gerald Director | 2021-06-10 18:57:40 | 65,223 0 | 65,223 | Form 4 |
| 29 | Koneru Mythili Chief Medical Officer | 2023-03-01 16:51:32 | 51,918 0 | 51,918 | Form 4 |
| 30 | Vera Juan President and CEO | 2025-02-14 17:17:32 | 50,000 0 | 50,000 | Form 4 |
| 31 | Garrett Gerald Vice President, Clinical Ops. | 2022-02-22 17:02:51 | 40,000 0 | 40,000 | Form 4 |
| 32 | Loiacono Michael Chief Accounting Officer | 2023-03-01 16:50:29 | 38,480 0 | 38,480 | Form 4 |
| 33 | BONFIGLIO JOHN N President and COO | 2017-03-13 16:01:27 | 26,054 10,417 | 36,471 | Form 4 |
| 34 | Reddish Mark Director | 2018-10-17 08:50:40 | 36,110 0 | 36,110 | Form 4 |
| 35 | Agopyan Nadia SVP, Regulatory Affairs | 2023-03-01 16:47:45 | 34,154 0 | 34,154 | Form 4 |
| 36 | Hoang Tsvetelina P VP, Research and Development | 2023-03-01 16:52:28 | 33,159 0 | 33,159 | Form 4 |
| 37 | Eansor Norman David Director | 2025-02-14 17:18:35 | 30,000 0 | 30,000 | Form 4 |
| 38 | Knobil Katharine Director | 2025-02-14 17:19:38 | 30,000 0 | 30,000 | Form 4 |
| 39 | ELMS STEVE Director | 2025-02-14 17:20:34 | 30,000 0 | 30,000 | Form 4 |
| 40 | Szymanska Anna Vice President, Quality | 2023-03-01 16:48:42 | 29,947 0 | 29,947 | Form 4 |
| 41 | MACKINNON NORMAN J R C A Director | 2004-02-17 17:30:04 | 25,000 0 | 25,000 | Form 3 |
| 42 | Grisewood Sherry Director | 2018-10-17 08:52:45 | 19,582 0 | 19,582 | Form 4 |
| 43 | Wilson John Robert Director | 2023-06-08 21:33:44 | 8,000 0 | 8,000 | Form 4 |
| 44 | Lurier Eliot M Interim CFO | 2023-07-05 16:22:14 | 0 0 | 0 | Form 3 |
| 45 | Moseley Ken General Counsel | 2018-12-28 16:12:51 | 0 0 | 0 | Form 3 |